FFG
DFTX

Ford Financial Group’s Definium Therapeutics DFTX Stock Holding History

Ford Financial Group’s Portfolio DFTX Stock Details DFTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-13
Closed – – 344
2021
Q4 		$0 Buy
+13
New +$415 ﹤0.01% 512
2021
Q3 		– Sell
-13
Closed – – 362
2021
Q2 		$0 Buy
+13
New +$682 ﹤0.01% 585

Other funds holding DFTX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DCI
Data Collective IV Palo Alto, California $55.9M AUM 49.14% 1-Year Est. Return
BB
Busey Bank Urbana, Illinois $3.68B AUM 26.6% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Swiss National Bank
Swiss National Bank Zurich, Switzerland $174B AUM 30.96% 1-Year Est. Return

Ford Financial Group's DFTX Position: Q1 2022 in Review

Ford Financial Group sold out of Definium Therapeutics (DFTX) in Q1 2022, closing a stake of 13 shares.

Ford Financial Group first reported a position in DFTX in Q2 2021 and held it in 2 quarters. The position peaked at $0 in Q4 2021. 159 funds tracked by Wall St. Rank hold DFTX as of Q1 2022.

  • Ford Financial Group reported no remaining Definium Therapeutics position as of Q1 2022 after selling out during the quarter.
  • Ford Financial Group sold 13 Definium Therapeutics shares in Q1 2022.
  • Ford Financial Group first reported a position in Definium Therapeutics in Q2 2021 and held it in 2 quarters.
  • Ford Financial Group's Definium Therapeutics position peaked at $0 in Q4 2021.
  • 159 funds tracked by Wall St. Rank held Definium Therapeutics as of Q1 2022.

Based on Ford Financial Group's 13F filing for Q1 2022, filed 13 Apr 2022.